We are live on
!
Find out more
PP
PDT Partners Portfolio holdings
AUM
$1.69B
1-Year Est. Return
74.01%
This Fund
S&P 500
This Quarter
Est. Return
+10.36%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.05B
AUM Growth
-$2.89B
(-73%)
Cap. Flow
-$2.96B
Cap. Flow
% of AUM
-281.28%
Top 10 Holdings %
Top 10 Hldgs %
16.51%
Holding
1,419
New
160
Increased
195
Reduced
212
Closed
815
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baxter International
BAX
|
+$19.4M |
| 2 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$19.4M |
| 3 |
MON
Monsanto Co
MON
|
+$17.8M |
| 4 |
Ecolab
ECL
|
+$17.1M |
| 5 |
Visteon
VC
|
+$13M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
YHOO
Yahoo Inc
YHOO
|
+$69.1M |
| 2 |
Gilead Sciences
GILD
|
+$59.1M |
| 3 |
Merck
MRK
|
+$54.1M |
| 4 |
Wells Fargo
WFC
|
+$53.8M |
| 5 |
X
US Steel
X
|
+$52.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 15.13% |
| 2 | Technology | 13.74% |
| 3 | Healthcare | 12.34% |
| 4 | Financials | 12.02% |
| 5 | Industrials | 7.41% |
Similar funds
ISS
GAM
BCM
FACM
TCBWMS
WAS
SGI
AAM
PDT Partners's Q4 2014 Portfolio in Review
As of Q4 2014, PDT Partners held 1,419 positions worth $1.05B, down 73% from $3.94B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
PDT Partners withdrew a net $2.96B in Q4 2014, closing 815 positions and reducing 212 holdings. Its most notable exit was Gilead Sciences, an estimated $59.1M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 13% a quarter earlier, followed by Technology and Healthcare.
Against the trend, PDT Partners opened a new position in Baxter International worth $19.8M.
- PDT Partners's largest Q4 2014 buy was Baxter International: 498,449 shares worth $19.8M.
- PDT Partners added most to Visteon in Q4 2014, an estimated $13M increase.
- PDT Partners's biggest Q4 2014 reduction was Yahoo Inc, cutting an estimated $69.1M.
- PDT Partners fully exited Gilead Sciences in Q4 2014, selling an estimated $59.1M.
- PDT Partners's ten largest holdings make up 17% of its $1.05B portfolio in Q4 2014.
- PDT Partners opened 160 new positions and closed 815 in Q4 2014.
- PDT Partners's portfolio value fell 73% quarter-over-quarter to $1.05B.
Based on PDT Partners's 13F filing for Q4 2014, filed 17 Feb 2015.